Tarrytown, NY, United States of America

Stefan Semrau

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Semrau

Introduction

Stefan Semrau is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of skin cancer. His innovative approaches have the potential to impact many lives.

Latest Patents

Stefan holds a patent for "Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors." This patent outlines methods for treating individuals with skin cancer and preventing the development of this disease. It also includes techniques for identifying subjects at an increased risk of developing skin cancer.

Career Highlights

Stefan is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research. His dedication to advancing medical science is evident in his innovative work and the impact it has on patient care.

Collaborations

Stefan collaborates with talented individuals such as Xinyuan Zhang and Julie Horowitz. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Stefan Semrau's contributions to the field of skin cancer treatment exemplify the importance of innovation in medicine. His work not only advances scientific understanding but also offers hope for improved patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…